Diffuse Mesothelioma - Biochemical Stages in the Diagnosis, Detection, and Measurement of Hyaluronic Acid in the Pleural Fluid

Our plain-English summary of Diffuse Mesothelioma - Biochemical Stages in the Diagnosis, Detection, and Measurement of Hyaluronic Acid in the Pleural Fluid, by A. Boersma, P. Degand, R. Havez (1973).

The study

• Authors: A. Boersma, P. Degand, R. Havez
• Published: BIOLOGICAL EFFECTS OF ASBESTOS (J.C. WAGNER, EDITOR), LYON: IARC SCIENTIFIC PUBLICATIONS, VOLUME 8, PP. 65-67 (1973)
• Type of article: Conference paper
• Our copy: from Johns-Manville's own medical library. The article is still under copyright, so we describe it here rather than post it.

In plain English

This short report described laboratory tests for detecting and measuring hyaluronic acid in pleural fluid, the fluid around the lungs, to help diagnose pleural mesothelioma. The article did not discuss asbestos exposure. The authors used electrophoresis to detect the acid and a column chromatography method to measure it. Since 1967 they had tested fluid from 474 cases of relapsing pleurisy with effusions that seemed to be caused by tumours but whose cause was generally uncertain. The test allowed a positive diagnosis in 50 cases. In 15 more, the acid was suspected and had to be confirmed by chromatography. Concentrations ranged from 5 to 500 mg per litre. Among the mesothelioma cases, the only negative one was a "pure fibrous" mesothelioma. One case of epidermoid bronchial cancer had 15 mg per litre. The authors reported never finding the acid in fluids or biopsies from secondary pleural tumours. Purulent pleurisy, earlier antimitotic treatment and heparin in the sample could confuse the test, and chemotherapy quickly lowered acid levels. The authors concluded that detecting hyaluronic acid seemed a decisive stage in diagnosing pleural mesothelioma, especially when pathology findings were inconclusive.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: laboratory diagnostic method study applied to a series of pleural fluid specimens
• Who was studied: 474 cases of relapsing pleurisy with effusions that seemed neoplastic (caused by tumours) but were of generally uncertain cause, tested since 1967; place not clearly stated in the readable text
• Main results:
  • Of 474 cases examined, the method allowed a positive diagnosis in 50 cases of pleurisy with hyaluronic acid
  • In 15 further cases hyaluronic acid was suspected but had to be confirmed by chromatographic fractionation; these had low levels (upper figure 10 mg per litre)
  • Hyaluronic acid concentrations in the fluids ranged from 5 to 500 mg per litre
  • Among the mesothelioma cases, the only negative case was what pathologists call a "pure fibrous" mesothelioma
  • One case of epidermoid bronchial cancer in the series had 15 mg of hyaluronic acid per litre of pleural fluid
  • The authors had never found hyaluronic acid in pleural fluids or biopsy material from secondary pleural tumours
  • In the authors' earlier 1965-1967 series, hyaluronic acid was consistently absent in 23 specimens of pleural fluid from secondary tumours
  • Local and general chemotherapy led rapidly to a fall in hyaluronic acid in the effusion fluid
• The authors' conclusion: The authors concluded that detecting hyaluronic acid in effusion fluid or tissue biopsy seemed a decisive stage in diagnosing pleural mesothelioma, and that the test's ease and high specificity made it extremely useful when pathological findings are inconclusive.
• Limitations the authors state:
  • Three sources of confusion: purulent pleurisy, previous antimitotic treatment that reduces hyaluronic acid levels, and heparin in the collected fluid hindering detection of slight traces
  • Diagnosis can be uncertain when only a slight trace of mucopolysaccharide, hardly visible by electrophoresis, is present

Topics

Medical terms in this study, explained in our Lexicon: Mesothelioma, Hyaluronic Acid, Pleural Mesothelioma, Asbestos Exposure, Pleurisy, Chemotherapy, Pathology.

Browse return to medical research.